Karen established Deloitte UK’s Centre for Health Solutions in November 2011. The Centre is the independent research arm of Deloitte’s Life Sciences and Health Care (LSHC) practices, providing a trusted source of relevant, timely and reliable insights on emerging trends, challenges, and solutions. The Centre combines creative thinking, robust research, and industry experience to develop evidence-based perspectives on some of the biggest and most challenging issues facing our life sciences and healthcare clients to help them to improve efficiency and cost-effectiveness and, importantly, benefit the patient.

Karen’ recent life sciences focus has been on a series of six reports on how AI is transforming the pharma value chain <a href=”https://www2.deloitte.com/uk/en/insights/industry/life-sciences/ai-in-biopharma.html?icid=learn_more_content_click” tabindex=”-1″>AI In Biopharma Collection | Deloitte Insights</a>; with the most recent being <a href=”https://www2.deloitte.com/uk/en/insights/industry/life-sciences/artificial-intelligence-in-healthcare-pharmacoviligance.html” tabindex=”-1″>AI in health care pharmacovigilance</a>.&nbsp; Previous research relevant to compliance includes a series of ten predictions on the life sciences and healthcare in the regulatory impact is a cross cutting theme – <a href=”https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/life-sciences-and-health-care-predictions.html” tabindex=”-1″>The future unmasked (deloitte.com)</a> <a href=”https://www2.deloitte.com/content/dam/Deloitte/uk/Documents/life-sciences-health-care/deloitte-uk-life-sciences-healthcare-predictions.pdf” tabindex=”-1″>deloitte-uk-life-sciences-healthcare-predictions.pdf</a> &nbsp;and an earlier report <a href=”https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/life-sciences-predictions-2025.html” tabindex=”-1″>A bold future for life sciences regulation | Deloitte UK</a>.

Karen is a member of the Institute of Chartered Public Finance and Accountants and has extensive experience in leading research into healthcare and life-science issues in the UK and internationally.&nbsp; Between 1997 and 2010 Karen was the Director of Health Value for Money (VFM) Audit at the UK’s National Audit Office, and received an OBE for her work on Health VFM work. Karen was a Non-Executive Director (NED) at Dartford and Gravesham NHS Trust from 2011 to 2021, where she chaired the Quality and Safety Committee for six years and the Audit Committee for four years. Since 2022 Karen has been a NED at Kent Community NHS Foundation Trust and a member of the Workforce and Quality and Safety Committees.